- Home
- INKT vs XTNT Comparison
INKT vs XTNT Comparison
Compare INKT & XTNT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- INKT
- XTNT
- Stock Information
- Founded
- INKT 2017
- XTNT N/A
- Country
- INKT United States
- XTNT United States
- Employees
- INKT N/A
- XTNT N/A
- Industry
- INKT Medicinal Chemicals and Botanical Products
- XTNT Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- INKT Health Care
- XTNT Health Care
- Exchange
- INKT Nasdaq
- XTNT Nasdaq
- Market Cap
- INKT 69.2M
- XTNT 82.1M
- IPO Year
- INKT 2021
- XTNT N/A
- Fundamental
- Price
- INKT $14.55
- XTNT $0.63
- Analyst Decision
- INKT Buy
- XTNT
- Analyst Count
- INKT 3
- XTNT 0
- Target Price
- INKT $37.50
- XTNT N/A
- AVG Volume (30 Days)
- INKT 45.1K
- XTNT 62.7K
- Earning Date
- INKT 11-13-2025
- XTNT 11-11-2025
- Dividend Yield
- INKT N/A
- XTNT N/A
- EPS Growth
- INKT N/A
- XTNT N/A
- EPS
- INKT N/A
- XTNT N/A
- Revenue
- INKT N/A
- XTNT $127,766,000.00
- Revenue This Year
- INKT N/A
- XTNT $13.03
- Revenue Next Year
- INKT N/A
- XTNT N/A
- P/E Ratio
- INKT N/A
- XTNT N/A
- Revenue Growth
- INKT N/A
- XTNT 15.16
- 52 Week Low
- INKT $4.56
- XTNT $0.33
- 52 Week High
- INKT $76.00
- XTNT $0.78
- Technical
- Relative Strength Index (RSI)
- INKT 48.69
- XTNT 50.21
- Support Level
- INKT $13.11
- XTNT $0.59
- Resistance Level
- INKT $15.09
- XTNT $0.67
- Average True Range (ATR)
- INKT 1.03
- XTNT 0.04
- MACD
- INKT 0.00
- XTNT 0.00
- Stochastic Oscillator
- INKT 46.57
- XTNT 36.45
About INKT MiNK Therapeutics Inc.
MiNK Therapeutics Inc is a clinical-stage biopharmaceutical company pioneering the discovery, development, and commercialization of allogeneic invariant natural killer T (iNKT) cell therapies to treat cancer and other immune-mediated diseases. The company is advancing a pipeline of both native and next generation engineered iNKT programs, with a platform designed to facilitate scalable and reproducible manufacturing for off-the-shelf delivery.
About XTNT Xtant Medical Holdings Inc.
Xtant Medical Holdings Inc is a medical technology company focused on the design, development, and commercialization of a comprehensive portfolio of orthobiologics and spinal implant systems to facilitate spinal fusion in complex spine, deformity and degenerative procedures. Its products are used by orthopedic spine surgeons and neurosurgeons to treat a variety of spinal disorders in the cervical, thoracolumbar, and interbody spine. The company's biomaterial products include OsteoSponge, OsteoSponge SC, OsteoSelect Plus DBM putty, OsteoWrap, and the line of 3Demin products, as well as other allografts. It generates a majority of its revenue from the U.S.